Eucrates Biomedical Acquisition Statistics Share Statistics Eucrates Biomedical Acquisition has n/a
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding n/a Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 1.59M Failed to Deliver (FTD) Shares 142 FTD / Avg. Volume 8.54%
Short Selling Information The latest short interest is 1.16K, so 0% of the outstanding
shares have been sold short.
Short Interest 1.16K Short % of Shares Out n/a Short % of Float 0.01% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is 5.37 and the forward
PE ratio is null.
Eucrates Biomedical Acquisition's PEG ratio is
0.12.
PE Ratio 5.37 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 3.49 P/FCF Ratio -47.22 PEG Ratio 0.12
Financial Ratio History Enterprise Valuation Eucrates Biomedical Acquisition has an Enterprise Value (EV) of 29.8M.
EV / Sales 0 EV / EBITDA -11.57 EV / EBIT -47.28 EV / FCF -47.28
Financial Position The company has a current ratio of 2.03,
with a Debt / Equity ratio of 0.01.
Current Ratio 2.03 Quick Ratio 2.03 Debt / Equity 0.01 Debt / EBITDA -0.02 Debt / FCF -0.1 Interest Coverage 0
Financial Efficiency Return on Equity is 64.88% and Return on Invested Capital is -12.88%.
Return on Equity 64.88% Return on Assets 44.36% Return on Invested Capital -12.88% Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -3.12M Effective Tax Rate -128.84%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is -0.07, so Eucrates Biomedical Acquisition's
price volatility has been lower than the market average.
Beta -0.07 52-Week Price Change n/a 50-Day Moving Average 10.1 200-Day Moving Average 10.01 Relative Strength Index (RSI) 33.61 Average Volume (20 Days) 1,662
Income Statement
Revenue n/a Gross Profit n/a Operating Income -699K Net Income 5.54M EBITDA -2.58M EBIT -699K Earnings Per Share (EPS) 1.86
Full Income Statement Balance Sheet The company has 18.86K in cash and 60.06K in
debt, giving a net cash position of -41.2K.
Cash & Cash Equivalents 18.86K Total Debt 60.06K Net Cash -41.2K Retained Earnings -3.72M Total Assets 12.49M Working Capital 67.06K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -630.29K
and capital expenditures 0, giving a free cash flow of -630.29K.
Operating Cash Flow -630.29K Capital Expenditures n/a Free Cash Flow -630.29K FCF Per Share -0.21
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
